Table 1: Socio-demographic, clinical, and psychosocial characteristics of study participants by general QoL (poor vs. good).

Variable Poor QoL Good QoL Total p-value *
Sex Female 34 (60.7%) 22 (39.3%) 56 (58.9%) 0.67
Male 22 (56.4%) 17 (43.6%) 39 (41.1%)
Age in years, mean (+SD) 38.1 (11.3) 32.6 (8.2) 35.8 (10.4) 0.01
Residence Urban 43 (58.9%) 30 (41.1%) 73 (76.8) 0.98
Rural 13 (59.1%) 9 (40.9%) 22 (23.2)
Current CD4 count mean (+SD) 305 (315) 278 (292) 293 (303.4) 0.68
HIV sero-status Known 51 (63%) 30 (37%) 81 (85.3) 0.056
New 5 (35.7%) 9 (64.3%) 14 (14.7)
Time since HIV diagnosis in years, mean (+SD) 4.1 (4.1) 4.9 (4.2) 4.5 (4.1) 0.36
cART status Yes 49 (61.3%) 31(38.8%) 80 (84.2) 0.29
No 7 (46.7%) 8 (53.3%) 15 (15.8)
Occupation Employed 16 (36.4%) 28 (63.6%) 44 (46.3) <0.001
Unemployed 40 (78.4%) 11 (21.6%) 51 (53.7)
Co-morbidity Yes 26 (83.9%) 5 (16.1%) 31 (32.6) 0.001
No 30 (46.9%) 34 (53.1%) 64 (67.4)
HIV disclosure Yes 28 (73.7%) 10 (26.3) 38 (40) 0.01
No 28 (49.1%) 29 (50.9%) 57 (60)
Support from family Yes 23 (43.4%) 30 (56.6%) 53 (55.8) 0.001
No 33 (78.6%) 9 (21.4%) 42 (44.2)

*P-values are from the chi-square tests for the categorical variables (sex, residence, HIV serostatus, cART status, co-morbidity, HIV disclosure, support from family); and from independent t-tests for the continuous variables (age, CD4 count, time since HIV diagnosis), using significance level of 0.05.